Pharmacology
Conference Coverage
Semaglutide boosts weight loss following endoscopic gastroplasty
Five patients in the combination group reverted to a nondiabetic state and were able to discontinue antidiabetic medications altogether.
News
FDA fast tracks testing of schizophrenia drug for impaired cognition
The breakthrough therapy designation and the initiation of phase 3 testing are based on results from a phase 2 clinical trial.
News
‘Overbasalization’ common in type 2 diabetes management
There are alternatives to giving insulin before meals to...
Conference Coverage
Rivaroxaban cut recurrent limb events in VOYAGER-PAD
Conference Coverage
Tezepelumab reduces serious exacerbations in severe asthma
News
FDA OKs nivolumab after surgery for esophageal or GEJ cancer: Practice-changing use of immunotherapy
A 1-year course of adjuvant nivolumab did not negatively impact patient-reported quality of life, the trialists reported.
Conference Coverage
GALACTIC-HF: Novel drug most effective in sickest HFrEF patients
In GALACTIC-HF trial, the greatest relative benefit of omecamtiv mecarbil was in the sickest HFrEF patients.
Conference Coverage
Sotagliflozin’s HFpEF benefit confirmed by new analyses
Conference Coverage
Herbal and dietary weight-loss supplements: No evidence that they work
Two reviews show that any weight loss effects of herbal and dietary compounds are minimal at best; there needs to be tighter regulation of the...
News
Depot buprenorphine a shot in the arm for opioid addiction?
“The study’s focus on patient-reported outcomes (PROs) can help to better inform patients and clinicians when selecting treatment options.”